Tenilsetam Inhibitor

Tenilsetam is an endonuclease modulator; a nootropic agent and advanced glycation end product (AGE) inhibitor having potential for Alzheimer's disease (AD) treatment.

Jennifer Hoffmann, Alex Alt, Jihong Lin, Gunther Lochnit,et al. Tenilsetam prevents early diabetic retinopathy without correcting pericyte loss. Thromb Haemost. 2006 Apr;95(4):689-95.
Jennifer Hoffmann, Alex Alt, Jihong Lin, Gunther Lochnit,et al. Tenilsetam prevents early diabetic retinopathy without correcting pericyte loss. Thromb Haemost. 2006 Apr;95(4):689-95.
Gyengesi E, Liang H, Millington C, et al. Investigation Into the Effects of Tenilsetam on Markers of Neuroinflammation in GFAP-IL6 Mice[J]. Pharm Res, 2018, 35(1):22.
Gyengesi E, Liang H, Millington C, et al. Investigation Into the Effects of Tenilsetam on Markers of Neuroinflammation in GFAP-IL6 Mice[J]. Pharm Res, 2018, 35(1):22.

Small volumes of Tenilsetam, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS5759368 is an inhibitor targeting Tenilsetam.